Stock Events

Stock Events

Search...

Fate Therapeutics (FATE) Q3 2025 Earnings

12AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.44

-0.39

-0.34

-0.29

Details

Expected EPS

-0.350833

Actual EPS

-0.29

Surprise EPS

0.06

Surprise Percent

+17.34%

Description

Fate Therapeutics (FATE) has reported earnings of -0.29 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.